Core Points - Shenzhen BGI Genomics Co., Ltd. announced a change in its continuous supervision sponsor representative [1] - CITIC Securities, the sponsor for the company's 2022 A-share IPO project, has replaced the original representative due to work adjustments [1] - The new sponsor representatives are Lu Ming and Wang Helin, ensuring the continuity of supervision duties [1] Summary by Sections - Company Announcement - The company confirms the authenticity and completeness of the announcement [2] - The board expresses gratitude to the outgoing representative for his contributions [1] - Change of Sponsor Representative - The original sponsor representative, Xiao Shaochun, is replaced by Wang Helin to maintain orderly supervision [1] - The continuous supervision period is set to last until December 31, 2025 [1]
深圳华大智造科技股份有限公司 关于变更持续督导保荐代表人的公告